DKK1 is an antagonist of the canonical Wnt signaling pathway (β‐catenin‐dependent pathway), but recent reports found that high DKK1 expression may lead to the aberrant activation of Wnt signaling and could activate the noncanonical Wnt signaling pathway in cancers.9 The gene discussed is DKK1; the disease is cancer.